Rising Incidence Of Cardiovascular Diseases (CVD) In The Elderly Driving Hemostasis Device Utilization In Surgeries: Transformative Forces Shaping the Hemostasis Diagnostic Devices And Equipment Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hemostasis Diagnostic Devices And Equipment Industry Market Size Be by 2025?
Recent years have seen rapid growth in the market size for hemostasis diagnostic devices and equipment. The market, which stood at $4.94 billion in 2024, is projected to increase to $5.66 billion in 2025, growing at a compound annual growth rate (CAGR) of 14.7%. Factors such as clinical diagnostics, surgical procedures, monitoring anticoagulant therapies, hemophilia, and bleeding disorders have contributed to this growth in the historical period.

What's the Long-Term Growth Forecast for the Hemostasis Diagnostic Devices And Equipment Market Size Through 2029?
In the coming years, the market size for diagnostic devices and equipment related to hemostasis is anticipated to experience accelerated growth. It is projected to reach $9.46 billion in 2029, growing at a compound annual growth rate (CAGR) of 13.7%. The expected growth during the forecast period is due to factors such as an aging population, the prevalence of cardiovascular and chronic illnesses, personalized healthcare, and increasing surgical procedures. The forecast period also predicts major trends like point-of-care testing, automatization, robotics, biomarker discovery, telemedicine, and remote patient monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

What Are the Key Growth Drivers Fueling the Hemostasis Diagnostic Devices And Equipment Market Expansion?
The growing frequency of disease diagnosis in older individuals is resulting in an uptick of cardiovascular surgeries utilizing hemostasis devices. The rising occurrence of diseases correlated with increasing age has led to more surgeries for the aging population. Hemostasis devices, known for their efficiency at accelerating the body's natural clotting mechanism, are being widely used. They can also provide crucial monitoring of anticoagulation and guidance in transfusion therapy during surgical procedures. The American Heart Association's report highlights that Americans aged 80 and above have a substantial risk of contracting cardiovascular disease (CVD)-approximately 83% of men and 87.1% of women are likely to experience some form of CVD. Consequently, hemostasis devices are being extensively used to enhance patient comfort and the success rate of surgeries.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp

What Long-Term Trends Will Define the Future of the Hemostasis Diagnostic Devices And Equipment Market?
The introduction of advanced and enhanced technology has emerged in the sector of hemostasis diagnostic device and equipment market. This new technology, such as collagen vascular hemostasis devices, is implemented towards improving the quality and success rates of surgeries. Derived from the primary structural protein discovered in skin and other connective tissues, collagen has been broadly utilized in a purified manner for cosmetic surgical procedures. Recently, it has also started being used in the hemostasis diagnostic devices market. On undergoing a femoral surgery, a patient can experience immobility which leads to increased discomfort. To mitigate this, collagen-based closure devices have been introduced. A survey conducted by the American Journal of Neuroradiology, encompassing 698 Angio-Seal closures, revealed that using the Angio-Seal reduced the average mobilization time by approximately 15 minutes, without causing any serious complications. The Angio-Seal, a kind of collagen hemostasis device, reduces the average hemostasis time and aids better patient mobilization.

How Is the Hemostasis Diagnostic Devices And Equipment Market Segmented?
The hemostasis diagnostic devices and equipment market covered in this report is segmented -

1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users

Subsegments:
1) By Analyzers: Hematology Analyzers, Platelet Function Analyzers, Thromboelastography (TEG) Analyzers
2) By Coagulation Instruments: Prothrombin Time (PT) Instruments, Activated Partial Thromboplastin Time (aPTT) Instruments, Fibrinogen Testing Instruments, Thrombin Time (TT) Instruments
3) By Other Hemostasis Instruments: Blood Clotting Time (BCT) Instruments, Bleeding Time (BT) Test Devices, Hemostatic Forceps and Clips
4) By Reagents and Kits: Coagulation Reagents, Blood Collection Kits, Point-of-care Testing Kits, Thrombosis Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2598&type=smp

Which Companies Are Leading the Charge in Hemostasis Diagnostic Devices And Equipment Market Innovation?
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton dic*kinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation

Which Regions Are Leading the Global Hemostasis Diagnostic Devices And Equipment Market in Revenue?
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2024. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2598

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.